¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Dextran 75 In Normal Saline IV"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal dwarf
    ±ÕÇü³­ÀïÀÌ, Á¤»ó³­ÀïÀÌ
  • normal endometrium
    Á¤»óÀڱ󻸷, Á¤»óÀڱüӸ·
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • normal flora
    Á¤»ó±Õ¹«¸®
  • normal full term delivery
    Á¤»ó¸¸±âºÐ¸¸
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
  • normal intestinal flora
    âÀÚÁ¤»ó±Õ¹«¸®, Àå³»Á¤»ó±Õ¹«¸®
  • normal limit
    Á¤»óÇѰè
  • normal occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • normal opsonin
    Á¤»ó¿É¼Ò´Ñ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¹°³úÁõ, Á¤»ó¾Ð¼öµÎÁõ
  • normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • normal dwarf
    Á¤»ó³­ÀåÀÌ
  • normal flora
    Á¤»ó±Õ¹«¸®
  • normal intestinal flora
    âÀÚÁ¤»ó±Õ¹«¸®
  • normal tension glaucoma
    Á¤»ó¾È¾Ð³ì³»Àå
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¹°³úÁõ, Á¤»ó¾Ð¼öµÎÁõ
  • normal limit
    Á¤»óÇѰè
  • normal
    Á¤»ó-, ³ë¸£¸»
  • normal opsonin
    Á¤»ó¿É¼Ò´Ñ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal state
    Á¤»ó»óÅÂ
  • normal value
    Á¤»óÄ¡
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • flora, normal
    Á¤»ó¼¼±ÕÃÑ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • hypothetical normal occlusion
    °¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
  • individual normal occlusion
    °³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
  • last normal menstrual period (LNMP)
    ÃÖÁ¾ Á¤»ó ¿ù°æÀÏ (õÌðû ïáßÈ êÅÌèìí)
  • last normal menstrual period =LNMP
    ÃÖÁ¾Á¤»ó¿ù°æ±â(õÌðûïáßÈêÅÌèÑ¢).
  • logarithmic normal distribution
    ·Î±×Á¤±ÔºÐÆ÷, ´ë¼öÁ¤±ÔºÐÆ÷(ÊÙËøË»ËÓ̰).
  • neutral occlusion =normal o.
    Á¤»ó±³ÇÕ.
  • normal
    1.Á¤»óÀÇ 2.³óµµÀÇ ´ÜÀ§,1±×·¥´ç·®/1000ml
  • normal bacterial flora
    Á¤»ó¼¼±ÕÃÑ.
  • normal curve
    Á¤±Ô°î¼±(ËøË»Ë­ËÛ).
  • normal diet
    º¸Åë½Ä(ÜÅ÷×ãÝ).
  • normal dispersion
    Á¤»óºÐ»ê(~ËÓË×).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PS pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy...
SI International System of Units [Fr. le Systeme International d'Unites]; sacroiliac; saline infusion; ...
SS disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-...
NBS N-bromosuccinimide; National Bureau of Standards; neuroblastoma supressor; nevoid basal cell carcino...
NL neural lobe; neutral lipid; nodular lymphoma; normal; normal libido, normal limits
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HS Hypertonic saline
HTS Hypertonic saline
HSS hypertonic saline solution
PBS Phosphate Buffer Saline
PBS Phosphate Buffered Saline
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • individual normal occlusion
    °³¼º Á¤»ó ±³ÇÕ
    Á¤»ó º¯À̳»¿¡ ÀÖ´Â °³ÀÎÂ÷¸¦ ÀÎÁ¤ÇÏ´Â Á¤»ó±³ÇÕ
  • normal adrenal function
    Á¤»óÀûÀÎ ºÎ½Å ±â´É
  • normal bacteriolysin
    Á¤»ó ¿ë±Õ¼Ò
  • normal curve
    Á¤»ó °î¼±, Á¤±Ô °î¼±
  • normal distribution
    Á¤±Ô ºÐÆ÷
  • normal eruption process
    Á¤»ó ¸ÍÃâ °úÁ¤
  • normal flora
    Á¤»ó ±ÕÃÑ, Á¤»ó ±ÕÃѱº
  • normal immunoglobulin
    Á¤»ó ¸é¿ª
  • normal occlusion
    Á¤»ó ±³ÇÕ
  • normal potential
    Á¤»ó ÀüÀ§
  • normal pressure hydrocephalus
    Á¤»ó¾Ð ¼öµÎÁõ
  • normal sinus rhythm
    Á¤»ó µ¿¹æ °áÀý ¸®µë
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • physilogic normal occlusion
    »ý¸®Àû Á¤»ó ±³ÇÕ
  • within normal limit
    Á¤»ó ¹üÀ§³»
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
dextran 75 Dextran (average MW 75,000) used as a plasma volume expander.
(05 Mar 2000)
dextran sulfate <chemical> Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4+ T-lymphocytes. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.
Pharmacological action: anticoagulant, antiviral agents, indicators and reagents, plasma substitutes.
Chemical name: Dextran, hydrogen sulfate
(12 Dec 1998)
dextrin-dextran transglucosidase A glucosyltransferase transferring 1,4-alpha-d-glucosyl residues, thus catalyzing the synthesis of dextrans (with 1,6 links between monosaccharide units) from dextrins (with 1,4 links) by glucose transfer.
Synonym: dextrin-dextran transglucosidase, dextrin 6-glucosyltransferase.
(05 Mar 2000)
iron-dextran complex <chemical> Iron dextran. A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a haematinic. (goodman and gilman's the pharmacological basis of therapeutics, 8th ed, p1292)
Pharmacological action: haematinics.
Chemical name: Iron dextran
(12 Dec 1998)
beta-normal <radiobiology> Beta-N, the normalised beta, is beta relative to the beta limit.
(09 Oct 1997)
big axillary nodes and normal breasts <radiology> Consider: lymphoma, leukaemia, rheumatoid arthritis
(12 Dec 1998)
gallium uptake with normal chest film <radiology> Pulmonary drug toxicity, tumour infiltration, sarcoidosis, pneumocystis carinii see: lung: gallium imaging
(12 Dec 1998)
range, normal Normal results can fall outside the normal range. By convention, the normal range is set to cover ninety-five percent (95%) of values from a normal population. Five percent (5%) of normal results therefore fall outside the normal range.
(12 Dec 1998)
human normal immunoglobulin A preparation of the proteins of liquid human plasma, containing the antibodies of normal adults; it is obtained from pooled liquid human plasma from a number of donors and may be prepared by precipitation with organic solvents under controlled conditions of pH, ionic strength, and temperature.
Synonym: human normal immunoglobulin.
(05 Mar 2000)
normal <microscopy> An imaginary line forming a right angle with the tangent to a curved surface at a particular point. It is used as a basis for determining angles of incidence, reflection, and refraction.
(05 Aug 1998)
normal animal In research, an experimental animal that has neither suffered an attack of a particular disease nor received an injection of a specific microorganism or its toxin.
(05 Mar 2000)
normal antibody Antibody demonstrable in the serum or plasma of various persons or animals not known to have been stimulated by specific antigen, either artificially or as the result of naturally occurring contact.
Synonym: natural antibody.
(05 Mar 2000)
normal antitoxin Serum that is capable of neutralizing an equivalent quantity of a normal toxin solution.
(05 Mar 2000)
normal bite That arrangement of teeth and their supporting structure which is usually found in health and which approaches an ideal or standard arrangement.
Synonym: normal bite.
Synonym: neutral occlusion.
(05 Mar 2000)
normal butyric acid (also written as n-butyric acid), butanoic acid, CH3CH2CH2COOH, which occurs in combination with glycerol in cow's butter; and isobutyric acid, 2-methylpropanoic acid, (CH3)2CHCOOH, one of the intermediates in valine catabolism, found in combination with glycerol in croton oil and elsewhere.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á